share_log

Citi Maintains Agilon Health(AGL.US) With Sell Rating, Cuts Target Price to $1.75

Futu News ·  Nov 13 20:31  · Ratings

Citi analyst Daniel Grosslight maintains $Agilon Health (AGL.US)$ with a sell rating, and adjusts the target price from $2.5 to $1.75.

According to TipRanks data, the analyst has a success rate of 50.0% and a total average return of 12.3% over the past year.

AnalystRecentRatingAutoNews_80414672886708_20241113_595fc3da5d1304d7b08179acd1c375e38a76455a_1731501011868114_nn_en

Furthermore, according to the comprehensive report, the opinions of $Agilon Health (AGL.US)$'s main analysts recently are as follows:

  • The company's third-quarter results highlight the challenges in gaining insight into current trends and the limited capacity to manage adverse developments.

  • Agilon Health's stock has experienced a 23% decline following its Q3 report. This trend is anticipated to persist until the company demonstrates its ability to widen medical margins and precisely forecast medical costs, especially after a substantial reduction in its profitability forecasts.

  • The firm has revised its model post-Q3 results, indicating that intermediate liquidity concerns may pose a risk, alongside the possibility of further physician partner attrition.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment